SYNOPSIS Subnormal red-cell folate values were encountered in 20 of 63 thalassaemic subjects in a population with a low incidence of megaloblastosis. The abnormality was not associated with haematological changes of megaloblastosis and could not be explained on the basis of incomplete liberation of intra-erythrocytic folates, serum conjugase deficiency or vitamin B12 deficiency.
In the absence offrank megaloblastosis, the diagnosis of folate deficiency is not straightforward. Hypersegmentation of circulating neutrophils is neither a specific (Chanarin et al, 1965 ) nor a sensitive (Hibbard and Hibbard, 1971) index. Increased urinary formiminoglutamic acid excretion after histidine load is found not only in folate deficiency but also in vitamin B12 deficiency (Knowles and Prankerd, 1962; Chanarin, 1964) , chronic liver disease (Carter et al, 1961) and other disease states (Grasbeck et al, 1961; Kershaw and Girdwood, 1964; Mohamed and Roberts, 1966) . Serum folate is largely maintained by an exchange between dietary folic acid and the storage folate (Chanarin and McLean, 1967) and may become reduced with relatively short periods of dietary deprivation (Herbert, 1962) even in the presence of notmal stores. Folates apparently gain entry into the red cell only at the stage of the marrow erythroblast but do not enter mature red cells in the circulation (Herbert and Zalusky, 1962; Neal and Williams, 1965) . Since red cells do not lose folate during their life span in the peripheral blood (Hansen and Weinfeld, 1962) , the folate content of circulating red cells will reflect the availability of folate some weeks earlier, at a time when they were being formed in the marrow. Where short-term fluctuations do not occur, red-cell folate is considered to be a useful index of the folate status.
So far the factor other than a low body folate status which may reduce red-cell folate is vitamin B12 deficiency (Cooper and Lowenstein, 1964; Hoffbrand et al, 1966 (Dacie and Lewis, 1968) . Methods for the determination of red cell volume and red cell survival have been described previously (Tso, 1972 (1966) for the estimation of red-cell folate has been evaluated as providing the optimum conditions for the maximal yield in healthy subjects (Omer, 1969) , but its efficacy in thalassaemia remains unknown. The present data show that while thalassaemic red cells are more resistant to osmotic lysis even to a tonicity of 30 mOsm/kg (Weatherall and Clegg, 1972) , the mixing at room temperature of 9 volumes of 1 % ascorbic acid (pH 2-6; 55 mOsm/kg) Herbert (1962) suggest that megaloblastosis is a late manifestation of folate deficiency. Furthermore, it has been postulated that the deficient haemoglobin synthesis in red cells in thalassaemia might render the morphological recognition of megaloblasts difficult (Chanarin, 1969) . Since vitamin B12 deficiency has been excluded in at least half of the patients, the possibility still exists that the subnormal red-cell folate in the present series of thalassaemic subjects represented a subclinical deficiency state even though erythropoiesis was normoblastic in all 11 marrows studied. This, however, appears unlikely for several reasons. Cr Tso(days) group.bmj.com on July 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from Significance ofsubnormal red-cellfolate in thalassaemia First, in the previously reported cases of folate deficiency in thalassaemic syndromes associated with normoblastic erythropoiesis, there was evidence of either marrow hypoplasia or megaloblastic granulopoiesis and all showed haematological response to folate therapy (Chanarin, 1969; Jandl and Greenberg, 1959; Luhby and Cooperman, 1961) . None of these was observed in the present study. Since a rise in red-cell folate value was seen after treatment, malabsorption or aberrant metabolism may be excluded. Secondly, there was a lack of correlation between the red-cell folate levels and the degree of anaemia or the severity of haemolysis among thalassaemic patients of a single variety, namely Hb H disease. Thirdly, if the 30% of the female patients in this study were having subclinical folate deficiency, it might be expected that at least a similar proportion of thalassaemic pregnancies would be complicated by folate deficiency but experience in this same population did not bear this out. For instance, Todd and Kan (1965) found no megaloblastosis in 38 thalassaemic pregnancies, and, more recently, Tso and Wong (1975) observed that none of 35 thalassaemic subjects had subnormal red-cell folate during late pregnancy and the puerperium.
It appears from these observations that subnormal red-cell folate may be found in a situation other than folate or vitamin B12 deficiency. It is also tempting to conclude that this is in some way related to the thalassaemic state. While the exact mechanism remains to be elucidated, caution must be exercised in interpreting subnormal red-cell folate values in thalassaemia, especially in the absence of frank megaloblastosis.
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